Richard Gilson

16.9k total citations · 1 hit paper
196 papers, 7.3k citations indexed

About

Richard Gilson is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Richard Gilson has authored 196 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Epidemiology, 96 papers in Infectious Diseases and 54 papers in Virology. Recurrent topics in Richard Gilson's work include HIV/AIDS Research and Interventions (76 papers), HIV Research and Treatment (53 papers) and Hepatitis B Virus Studies (46 papers). Richard Gilson is often cited by papers focused on HIV/AIDS Research and Interventions (76 papers), HIV Research and Treatment (53 papers) and Hepatitis B Virus Studies (46 papers). Richard Gilson collaborates with scholars based in United Kingdom, United States and Australia. Richard Gilson's co-authors include Mala K. Maini, Andrew Phillips, Richard S. Tedder, Caroline Sabin, Alison Rodger, Margaret Johnson, Dimitra Peppa, Antonio Bertoletti, Ian Weller and Martin Fisher and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Richard Gilson

194 papers receiving 7.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection

2000 658 citations Richard Gilson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Richard Gilson	4.4k	3.0k	2.4k	1.5k	1.1k	196	7.3k
Steven Kleinman	4.5k 1.0×	3.3k 1.1×	3.1k 1.3×	1.8k 1.2×	1.2k 1.1×	202	14.1k
Janaki Amin	3.3k 0.8×	2.5k 0.8×	2.3k 1.0×	1.7k 1.1×	559 0.5×	217	7.0k
Jacquie Astemborski	4.6k 1.0×	2.0k 0.7×	3.5k 1.5×	1.2k 0.8×	1.5k 1.3×	115	7.2k
Ian Weller	2.6k 0.6×	2.7k 0.9×	1.1k 0.5×	1.8k 1.2×	688 0.6×	97	5.7k
Kimberly Page	5.2k 1.2×	3.6k 1.2×	2.2k 0.9×	1.7k 1.2×	678 0.6×	213	8.5k
R A Coutinho	3.1k 0.7×	2.6k 0.9×	914 0.4×	1.9k 1.2×	770 0.7×	154	5.9k
Angelos Hatzakis	4.7k 1.1×	2.5k 0.8×	3.4k 1.4×	932 0.6×	297 0.3×	221	7.0k
Dominique Salmon‐Céron	2.2k 0.5×	2.0k 0.7×	1.1k 0.5×	931 0.6×	430 0.4×	161	4.8k
Jan Gerstoft	3.0k 0.7×	4.8k 1.6×	558 0.2×	3.6k 2.4×	1.1k 1.0×	303	9.2k
John S. Lambert	1.7k 0.4×	2.4k 0.8×	616 0.3×	1.5k 1.0×	414 0.4×	215	4.8k

Countries citing papers authored by Richard Gilson

Since Specialization

Citations

This map shows the geographic impact of Richard Gilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Gilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Gilson more than expected).

Fields of papers citing papers by Richard Gilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Gilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Gilson. The network helps show where Richard Gilson may publish in the future.

Co-authorship network of co-authors of Richard Gilson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Gilson. A scholar is included among the top collaborators of Richard Gilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Gilson. Richard Gilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hammond, Robert, Valentina Cambiano, Fiona Lampe, et al.. (2023). Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective study. Sexually Transmitted Infections. 99(7). 474–481. 5 indexed citations

Okhai, Hajra, Caroline Sabin, Lorraine Sherr, et al.. (2022). Obesity in women living with HIV aged 45–60 in England: An analysis of the PRIME study. HIV Medicine. 23(4). 371–377. 8 indexed citations

Cambiano, Valentina, Janey Sewell, Alison Rodger, et al.. (2021). Trends in HIV incidence between 2013–2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study. PLoS Medicine. 18(6). e1003677–e1003677. 16 indexed citations

Cameron, Sharon, Anna Glasier, Lisa McDaid, et al.. (2021). Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCT. Health Technology Assessment. 25(27). 1–92. 3 indexed citations

Tariq, Shema, Fiona Burns, Richard Gilson, et al.. (2021). Ethnic inequalities in mental health and socioeconomic status among older women living with HIV: results from the PRIME Study. Sexually Transmitted Infections. 98(2). 128–131. 13 indexed citations

Gilson, Richard, Diarmuid Nugent, Kate Bennett, et al.. (2020). Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT. Health Technology Assessment. 24(47). 1–86. 21 indexed citations

Nugent, Diarmuid, Oliver Stirrup, Sarah Pett, et al.. (2020). Performance of human papillomavirus DNA detection in residual specimens taken forChlamydia trachomatisandNeisseria gonorrhoeaenucleic acid amplification testing in men who have sex with men. Sexually Transmitted Infections. 97(7). 541–546. 1 indexed citations

Gilson, Richard, Diarmuid Nugent, Ricardo Niklas Werner, J. M. Ballesteros, & Jonathan Ross. (2020). 2019 IUSTI‐Europe guideline for the management of anogenital warts. Journal of the European Academy of Dermatology and Venereology. 34(8). 1644–1653. 63 indexed citations

King, Carina, Carrie Llewellyn, Maryam Shahmanesh, et al.. (2019). Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study. Health Technology Assessment. 23(12). 1–122. 11 indexed citations

10.

Sewell, Janey, Valentina Cambiano, Andrew Speakman, et al.. (2019). Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study. International Journal of Drug Policy. 68. 54–61. 77 indexed citations

11.

Murray, Macey L., Caroline J Doré, Andrew Copas, et al.. (2018). Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial). BMC Medical Research Methodology. 18(1). 125–125. 21 indexed citations

12.

Lechner, Matt, Oliver Jones, James Howard, et al.. (2018). A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK. BMJ Open. 8(7). e023339–e023339. 19 indexed citations

13.

Burns, Fiona, et al.. (2017). 'You're suffering all these things and you keep going backwards and forwards': experiences of the menopause among women living with HIV in the United Kingdom. UCL Discovery (University College London). 4 indexed citations

14.

Sewell, Janey, Ada Miltz, Fiona Lampe, et al.. (2017). Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. International Journal of Drug Policy. 43. 33–43. 166 indexed citations

15.

Gourlay, Annabelle, Julie Fox, Mitzy Gafos, et al.. (2017). A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England. BMJ Open. 7(8). e016494–e016494. 14 indexed citations

16.

Sewell, Janey, Andrew Speakman, Andrew Phillips, et al.. (2016). Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study). JMIR Research Protocols. 5(2). e128–e128. 7 indexed citations

17.

Kall, Meaghan, Anthony Nardone, Valérie Delpech, Richard Gilson, & Maryam Shahmanesh. (2015). 'Positive Voices' a survey of the behaviour, experiences, and healthcare needs of people living with HIV: A pilot study methods and respondent characteristics. UCL Discovery (University College London).

18.

Turner, Jeffrey D., Emma Aarons, H. James Price, et al.. (2010). Hepatitis C viral load in semen of HIV-positive men during acute and chronic hepatitis C infection. UCL Discovery (University College London). 2 indexed citations

19.

Leen, Clifford, Jonathan Ainsworth, J. Anderson, et al.. (2009). Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? United Kingdom Collaborative HIV Cohort Study Group. UCL Discovery (University College London). 7 indexed citations

20.

Bhaskaran, Krishnan, Deenan Pillay, A. Sarah Walker, et al.. (2004). Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters. AIDS. 18(10). 1471–1473. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact